Outcome for all patients excluding those with favorable and unfavorable sentinel cytogenetic lesions: DS-ALL versus non–DS-ALL. (A) EFS. (B) OS. Patients with ETV6-RUNX1, BCR-ABL1, MLL translocations, or trisomy of both chromosomes 4 and 10 are excluded.